Mathieu Lupien
@MatLupien
Senior scientist @Princess Margaret Cancer Centre, Prof @ UofT. BHAG: Conquer cancer by treating it as a disease of the chromatin. Also on Bluesky
Are you currently in the ERE related field and want to find new collaborative opportunities? Join our Chairs @ChiappinelliLab, @shenhui1986, @twang5 & @paultaowu at the upcoming Endogenous Retrotransposable Elements & Human Diseases Conference this November! #EREHD25 🎙️Talk…
A jewel of a presentation on the history of chromatin. Always a pleasure to go back in time with those who helped shape it. I am grateful for the insights and stories shared by Drs. Ada and Donald Olins. youtu.be/QExPH1bVbGU
Less than a month to go until the GRC on Hormone-Dependent Cancers! Looking forward to reconnecting with the community and sharing our latest on epigenomics of ecDNAs in tumor evolution. Hope to see you then. grc.org/hormone-depend…
@MatLupien we are looking forward to your presentation at #EREHD25 in Mexico this November🧬 Please share with your followers to let them know our early bird & talk submission deadline has been extended, so submit & register today! 🔗bit.ly/4kNH98y
If you're into super-resolution microscopy, check out the new study from Myles Brown's lab showing dynamic, ligand-dependent changes in H3K27ac structure with implications for endocrine resistance. biorxiv.org/content/10.110…
🚨 New meeting this fall in Brussels! 🚨 Cutting-edge science, amazing colleagues, & a RARE career development workshop for trainees-covering pharma, consulting, writing, start-ups & more 🤩 #epigenetics2025 Registration is open!! @epicypher @FuksLab xcellsconferences.com/epigenetics2025
Big news! Recursion is a sponsor for the 2025 Cancer Genetics and Epigenetics GRC! With Recursion (recursion.com), this GRC conference is one where advanced technologies and human ingenuity will converge to outsmart cancer’s complexity. Join us grc.org/cancer-genetic…
🌟What is epigenetics and why is it crucial for cancer research? Meet Dr. @MatLupien at @UHN @pmcancercentre, newly elected Fellow of the Royal Society of Canada. His work in cancer epigenetics is transforming how we can treat breast and prostate cancer: uhnresearch.ca/news/meet-dr-m…
Epigenome Technologies Inc. is our latest partner of choice for the 2025 Cancer Genetics & Epigenetics GRC! 🔍 Discover their cutting-edge single-cell histone and transcription factor profiling technologies: epigenome.us
#singlecell epigenomic technologies are redefining our understanding of cancer evolution. Now, @MartheLaisne, @MatLupien & @VallotCeline explain how epigenomic heterogeneity drives tumor cell state diversity through reprogramming and selection. go.nature.com/3NyflWN
📖 New review in Nature Reviews Cancer on how epigenomic heterogeneity drives tumour evolution! We dive into: Check it out if you're into epigenetics, single-cell tech, or the future of cancer therapy! 📖 nature.com/articles/s4156…
📝Epigenomic heterogeneity as a source of tumour evolution Just out in Nature Reviews Cancer - a piece we wrote with @MatLupien and @MartheLaisne, a fantastic team work and such a pleasure to exchange & confront ideas on cancer epigenetics. 👉nature.com/articles/s4156…
We are recruiting a colleague in the Donnelly Centre at the University of Toronto. We are looking for an assistant professor in the broad area of functional genomics: jobs.utoronto.ca/job/Toronto-As… closing date is Jan 16, 2025 @DonnellyCentre @UofT @uoftmedicine
📣Sharing the latest research from the @MRSantosLab, just released on bioRxiv! We found LINE1 RNA promotes nuclear compartmentalization to repress the 8-cell state in human embryonic stem cells. biorxiv.org/content/10.110… 👇Key findings:
🚨 BIG NEWS! 🚨 We are thrilled to welcome @biomodalhq as a sponsor for the 2025 Cancer Genetics & Epigenetics @GordonConf ! Their cutting-edge 6-base DNA sequencing technology is a game-changer in the field. 🌐 Learn more at biomodal.com Changing the game—together!